Makers Laboratories Reports Mixed Financial Results Amid Sales Growth and Liquidity Concerns
Makers Laboratories has reported its financial results for the quarter ending June 2025, showcasing its highest quarterly net sales in five quarters at Rs 35.00 crore. However, the company faces liquidity challenges, with cash and cash equivalents at a low of Rs 0.65 crore and a declining debtors turnover ratio.
Makers Laboratories, a microcap company in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending June 2025. The results, declared on August 8, 2025, indicate a notable adjustment in evaluation, with the score declining to 4 from 13 over the past three months.The financial data reveals that Makers Laboratories achieved its highest quarterly net sales in the last five quarters, reaching Rs 35.00 crore. This suggests a positive near-term sales trend, reflecting some strength in revenue generation.
However, the company is facing challenges as well. The cash and cash equivalents for the half-yearly period have reached their lowest point in the last six periods, recorded at Rs 0.65 crore, indicating a decline in short-term liquidity. Additionally, the debtors turnover ratio has also hit a low of 4.37 times over the last five half-yearly periods, suggesting a slowdown in the pace at which the company is settling its debts.
Overall, the financial results for Makers Laboratories highlight a mixed performance, with both positive sales trends and significant liquidity concerns.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
